Local adjunct effect of antimicrobial photodynamic therapy for the treatment of chronic periodontitis in type 2 diabetics: split-mouth double-blind randomized controlled clinical trial. Issue 8 (November 2016)

• Record Type: Journal Article
• Authors: Castro dos Santos, Nídia; Andere, Naira; Araujo, Cássia; Marco, Andrea; Santos, Lúcio; Jardini, Maria; Santamaria, Mauro
• Is Part Of: Lasers in medical science. Volume 31:Issue 8(2016)
• Page Start: 1633
• Page End: 1640
• Publication Date: 2016-11
• Subjects: Diabetes mellitus -- Chronic periodontitis -- Periodontal pocket -- Antimicrobial therapy -- Photodynamic therapy -- Low-level laser therapy; Lasers in medicine -- Periodicals; 610.28
• DOI: 10.1007/s10103-016-2030-8
• Languages: English
• ISSNs: 0268-8921

Abstract

Abstract Diabetes has become a global epidemic. Its complications can have a significant impact on quality of life, longevity, and public health costs. The presence of diabetes might impair the prognosis of periodontal treatments due to its negative influence on wound healing. Antimicrobial photodynamic therapy (aPDT) is a local approach that can promote bacterial decontamination in periodontal pockets. The aim of this study was to investigate the local effect of adjunct aPDT to ultrasonic periodontal debridement (UPD) and compare it to UD only for the treatment of chronic periodontitis in type 2 diabetic patients. Twenty type 2 diabetic patients with moderate to severe generalized chronic periodontitis were selected. Two periodontal pockets with probing depth (PD) and clinical attachment level (CAL) ≥5 mm received UPD only (UPD group) or UPD plus adjunct aPDT (UPD + aPDT group). Periodontal clinical measures were collected and compared at baseline and 30, 90, and 180 days. After 180 days of follow-up, there were statistically significant reductions in PD from 5.75 ± 0.91 to 3.47 ± 0.97 mm in the UPD group and from 6.15 ± 1.27 to 3.71 ± 1.63 mm in the UPD + aPDT group. However, intergroup analysis did not reveal statistically significant differences in any of the evaluated clinical parameters (p > 0.05). The adjunct application of aPDT to UPD did not present additional benefits for the treatment of chronic periodontitis in type 2 diabetic patients. TheClinicalTrials.gov identifier of the present study is NCT02627534.